Clinical Trial Update: Combination of Irinotecan and Temozolomide in Children With Brain Tumors. [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the combination of irinotecan and temozolomide in children with brain tumors (glioma and medulloblastoma) has completed with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioma
• Medulloblastoma

Drugs mentioned

• Irinotecan (Irinotecan)
• Temodar (Temozolomide)

Snippet

Sponsor: Pfizer | Conditions: Glioma, Medulloblastoma | Phase 2 | Status: COMPLETED | Results posted: 2012-02-17